Results 51 to 60 of about 10,740,045 (356)

Invariant NKT cells and rheumatic disease: Focus on primary sjogren syndrome [PDF]

open access: yes, 2019
Primary Sjogren syndrome (pSS) is a complex autoimmune disease mainly affecting salivary and lacrimal glands. Several factors contribute to pSS pathogenesis; in particular, innate immunity seems to play a key role in disease etiology.
Barbera L. L.   +5 more
core   +1 more source

Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea

open access: yesArthritis Research & Therapy, 2021
Background This study aimed to evaluate the crude incidence rates and relative risk of malignancy in Korean patients with SLE. Methods We conducted a retrospective nationwide cohort study using databases from the National Health Insurance Service in ...
Jung-Yong Han   +5 more
doaj   +1 more source

Reduced Humoral Response of SARS-CoV-2 Antibodies following Vaccination in Patients with Inflammatory Rheumatic Diseases—An Interim Report from a Danish Prospective Cohort Study

open access: yesVaccines, 2021
Background/Purpose: In light of the current COVID-19 pandemic, whether patients with rheumatic musculoskeletal disease (RMD) treated with conventional (cs) or biologic (b) disease-modifying drugs (DMARDs) exhibit an adequate immune response to the ...
Karen Schreiber   +8 more
doaj   +1 more source

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

open access: yesThe Lancet Rheumatology, 2021
Background Various observations have suggested that the course of COVID-19 might be less favourable in patients with inflammatory rheumatic and musculoskeletal diseases receiving rituximab compared with those not receiving rituximab.
J. Avouac   +464 more
semanticscholar   +1 more source

Consensus of Chinese Experts on the Diagnosis and Treatment of Type Ⅰ Interferonopathy

open access: yes罕见病研究
Type Ⅰ interferonopathy is an autoinflammatory disease that affects multiple systems, with a high disability and mortality rate. It profoundly impacts the quality of life of patients and poses a considerable burden on their families and society.
Chinese Alliance of Pediatric Rheumatic & Immunologic Diseases   +1 more
doaj   +1 more source

Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report

open access: yesClinical Case Reports, 2020
We treated PR3‐ANCA positive vasculitis in a patient diagnosed with rheumatoid arthritis using rituximab. Monoclonal antibody therapy can be used to simultaneous treat more than one collagen disease in such patients.
Akihiro Yamada   +2 more
doaj   +1 more source

Quantitative sensory testing in painful hand osteoarthritis demonstrates features of peripheral sensitisation. [PDF]

open access: yes, 2012
Hand osteoarthritis (HOA) is a prevalent condition for which treatments are based on analgesia and physical therapies. Our primary objective was to evaluate pain perception in participants with HOA by assessing the characteristics of nodal involvement ...
Ejindu, V   +5 more
core   +2 more sources

Association of Painful musculoskeletal conditions and migraine headache with mental and sleep disorders among adults with disabilities, Spain, 2007-2008. [PDF]

open access: yes, 2014
Introduction: The aim of the study was to determine the prevalence of musculoskeletal painful conditions and migraine/headache in a population with disabilities, and their association with anxiety, depression and sleep disorders.
Agüera   +27 more
core   +2 more sources

The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases

open access: yesAnnals of Laboratory Medicine, 2019
The platelet-to-lymphocyte ratio (PLR) has emerged as an informative marker revealing shifts in platelet and lymphocyte counts due to acute inflammatory and prothrombotic states.
A. Gasparyan   +4 more
semanticscholar   +1 more source

Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients

open access: yesArthritis Research & Therapy, 2021
Objective To evaluate the effectiveness of bazedoxifene in preventing bone loss in patients with rheumatoid arthritis (RA) receiving low-dose glucocorticoids (GCs).
Soo-Kyung Cho   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy